Reportlinker Adds 2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Insulin Injection Pens
NEW YORK, March 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. Type 2 diabetes is most common in patients that are of 45 years or greater, have a high-density lipoprotein (HDL) cholesterol of less than 35 mg/dL or triglyceride level of greater than 250 mg/dL, and/or have high blood pressure. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication.
Table of Contents
Chapter 1: Research Background and Objectives 5-7
Chapter 2: Method Details 8-10
Chapter 3: Executive Summary 11-17
Chapter 4: Awareness of Insulin Injection Pen Brands 18-20
Chapter 5: Usage of Insulin Injection Pens 21-28
Chapter 6: Preferred Features of Insulin Injection Pens 29-32
Chapter 7: Satisfaction with and Future Intentions toward Current Brand 33-43
Chapter 8: Overall Brand Performance 44-50
Appendix 51-54
About Frost & Sullivan 55-63
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article